Kemble George
Sagimet Biosciences Inc. · Executive Chairman
Kemble George is listed in filings as Executive Chairman at Sagimet Biosciences Inc.. This profile follows SEC Form 4 activity through Nov 21, 2025, including sale activity. Recent filings connect the profile to Sagimet Biosciences Inc. (SGMT). The current snapshot covers public activity from Jul 23, 2024 to Nov 21, 2025. Reported amounts are shown as $43.6K to $171.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $290k37.7k shares | SellNov 20, 2025 | $7.69 | $7.65 |